Hologic Valuation

HO1 Stock  EUR 59.50  1.00  1.65%   
At this time, the firm appears to be overvalued. Hologic retains a regular Real Value of €51.77 per share. The prevalent price of the firm is €59.5. Our model calculates the value of Hologic from evaluating the firm fundamentals such as Return On Asset of 0.0858, return on equity of 0.21, and Current Valuation of 18.25 B as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
59.50
59.559.551.851.7759.559.556.756.74100%
Please note that Hologic's price fluctuation is very steady at this time. Calculation of the real value of Hologic is based on 3 months time horizon. Increasing Hologic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Hologic stock is determined by what a typical buyer is willing to pay for full or partial control of Hologic. Since Hologic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hologic Stock. However, Hologic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  59.5 Real  51.77 Hype  59.5 Naive  56.74
The real value of Hologic Stock, also known as its intrinsic value, is the underlying worth of Hologic Company, which is reflected in its stock price. It is based on Hologic's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hologic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
51.77
Real Value
65.45
Upside
Estimating the potential upside or downside of Hologic helps investors to forecast how Hologic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hologic more accurately as focusing exclusively on Hologic's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
58.7265.6272.52
Details
Hype
Prediction
LowEstimatedHigh
57.8959.5061.11
Details
Naive
Forecast
LowNext ValueHigh
55.1356.7458.35
Details

Hologic Total Value Analysis

Hologic is currently estimated to have takeover price of 18.25 B with market capitalization of 18.19 B, debt of 2.81 B, and cash on hands of 601.8 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Hologic fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
18.25 B
18.19 B
2.81 B
601.8 M

Hologic Investor Information

About 100.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 20.66. The company has Price/Earnings To Growth (PEG) ratio of 0.91. Hologic had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Hologic's historical financial statements, Hologic is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.

Hologic Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hologic has an asset utilization ratio of 53.61 percent. This implies that the Company is making €0.54 for each dollar of assets. An increasing asset utilization means that Hologic is more efficient with each dollar of assets it utilizes for everyday operations.

Hologic Ownership Allocation

Hologic has a total of 246.55 Million outstanding shares. The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Also note that almost one million seven hundred seventy-five thousand one hundred eighty-nine invesors are currently shorting Hologic expressing very little confidence in its future performance.
P...

Hologic Profitability Analysis

The company reported the revenue of 4.86 B. Net Income was 1.3 B with profit before overhead, payroll, taxes, and interest of 3.31 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hologic's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hologic and how it compares across the competition.

About Hologic Valuation

The stock valuation mechanism determines Hologic's current worth on a weekly basis. Our valuation model uses a comparative analysis of Hologic. We calculate exposure to Hologic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hologic's related companies.
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. HOLOGIC INC is traded on Frankfurt Stock Exchange in Germany.

8 Steps to conduct Hologic's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Hologic's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Hologic's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Hologic's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Hologic's revenue streams: Identify Hologic's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Hologic's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Hologic's growth potential: Evaluate Hologic's management, business model, and growth potential.
  • Determine Hologic's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Hologic's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Hologic Stock analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals